Symbols

NSPR

InspireMD·NASDAQ

--(--)

NSPR Profile

Inspiremd, Inc.

A developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke

Industry

Healthcare Equipment and Supplies

Established Date

02/29/2008

Listing Date

05/24/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

127

Fiscal Year Ends

12-31

Website

www.inspiremd.com

Security Type

Common stock

Office address

6303 Waterford District Drive, Suite 215, Miami, Florida 33126

Business

Introduction

InspireMD, Inc., was incorporated in Delaware on February 29, 2008. The company is a medical device company focused on the development and commercialization of products for the treatment of carotid artery disease, with CGuard carotid stent technology at its core. Its product portfolio includes CGuard EPS and CGuard Prime, designed to provide embolic protection during stent implantation, of which CGuard Prime has been approved for sale in the US market.